Qian Xiao Jie - Net Worth and Insider Trading
Qian Xiao Jie Net Worth
The estimated net worth of Qian Xiao Jie is at least $1 Million dollars as of 2024-06-24. Qian Xiao Jie is the senior management of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd and owns about 92,430 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) stock worth over $1 Million. Details can be seen in Qian Xiao Jie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Qian Xiao Jie has not made any transactions after 2022-07-11 and currently still holds the listed stock(s).
Transaction Summary of Qian Xiao Jie
Qian Xiao Jie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Qian Xiao Jie owns 1 companies in total, including Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) .
Click here to see the complete history of Qian Xiao Jie’s form 4 insider trades.
Insider Ownership Summary of Qian Xiao Jie
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:603707 | Nanjing King-Friend Biochemical Pharmaceutical Co Ltd | 2022-07-11 | senior management |
Qian Xiao Jie Latest Holdings Summary
Qian Xiao Jie currently owns a total of 1 stock. Qian Xiao Jie owns 92,430 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) as of July 11, 2022, with a value of $1 Million.
Latest Holdings of Qian Xiao Jie
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:603707 | Nanjing King-Friend Biochemical Pharmaceutical Co Ltd | 2022-07-11 | 92,430 | 11.94 | 1,103,614 |
Holding Weightings of Qian Xiao Jie
Qian Xiao Jie Form 4 Trading Tracker
According to the SEC Form 4 filings, Qian Xiao Jie has made a total of 1 transactions in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is the sale of 21,330 shares on July 11, 2022, which brought Qian Xiao Jie around $0.
Insider Trading History of Qian Xiao Jie
- 1
Qian Xiao Jie Trading Performance
GuruFocus tracks the stock performance after each of Qian Xiao Jie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Qian Xiao Jie is -24.99%. GuruFocus also compares Qian Xiao Jie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Qian Xiao Jie within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Qian Xiao Jie's insider trading performs compared to the benchmark.
Performance of Qian Xiao Jie
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.94 |  | | | | |
| Relative Return to S&P 500(%) | -16.09 | | | | | |
Qian Xiao Jie Ownership Network
Qian Xiao Jie Owned Company Details
What does Nanjing King-Friend Biochemical Pharmaceutical Co Ltd do?
Who are the key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd?
Qian Xiao Jie is the senior management of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd. Other key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd include Supervisors Liu Zu Qing , and senior management Wu Gui Ping .
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Insider Transactions
Qian Xiao Jie Mailing Address
Above is the net worth, insider trading, and ownership report for Qian Xiao Jie. Currently GuruFocus does not have mailing address information for Qian Xiao Jie.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
